6,205
Views
21
CrossRef citations to date
0
Altmetric
ACTA ONCOLOGICA LECTURE

Gastrointestinal consequences of cancer treatment and the wider context: A bad gut feeling

Pages 297-306 | Received 25 Oct 2013, Accepted 27 Nov 2013, Published online: 27 Jan 2014

References

  • Maher J, McConnell H. New pathways of care for cancer survivors: Adding the numbers. Br J Can 2011;105:S5–10.
  • Andreyev HJN, Davidson S, Gillespie C, Allum W, Swarbrick E. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 2012;61:179–92.
  • Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, et al. Patients’ supportive care needs beyond the end of treatment: A prospective and longitudinal survey. J Clin Oncol 2009;27:6172–9.
  • Abayomi J, Kirwan J, Hackett A. The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life. Eur J Oncol Nurs 2009;13:262–7.
  • Gibson R, Keefe D. Cancer chemotherapy-induced diarrhoea and constipation: Mechanisms of damage and prevention strategies, J Support Care Cancer 2006;14: 890–900.
  • Cancer Research UK 2012. Incidence of cancer diagnosis in the UK. [cited 2013 Feb 09]. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/prevalence/prevalence-uk
  • Andreyev HJN. Gastrointestinal symptoms after pelvic radiotherapy: A new understanding to improve management of symptomatic patients. Lancet Oncol 2007;8:1007–17.
  • Martin M, Lefaix JL, Delanian S. TGF-ß1 and radiation fibrosis: A master switch and a specific therapeutic target?Int J Radiat Oncol Biol Phys 2000;47:277–90.
  • Denham J, Hauer-Jensen M. The radiotherapeutic injury: A complex ‘wound’. Radiother Oncol 2002;63:129–45.
  • Westbury CB, Yarnold JR. Radiation fibrosis – current clinical and therapeutic perspectives. Clin Oncol 2012; 24:1–16.
  • Trott K, Doerr W, Facoetti A, Hopewell J, Langendijk J, van Luijk P, et al. Biological mechanisms of normal tissue damage: Importance for the design of NTCP models. Radiother Oncol 2012;105:79–85.
  • Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peut I, Osman A, et al. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 2007;96:1001–7.
  • Takeuchi H, Kimura T, Okamoto K, Aoyagi E, Miyamoto H, Kaji M, et al. A mechanism for abnormal angiogenesis in human radiation proctitis: Analysis of expression profile for angiogenic factors. J Gastroenterol 2012;47:56–64.
  • Gurtner G, Werner S, Barrandon Y, Longaker M. Wound repair and regeneration. Nature 2008;453:314–21.
  • Benton B, Norton C, Lindsay J, Dolan S, Andreyev HJN. Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease?Clin Oncol 2011;23:538–51.
  • Capp A, Inostroza-Ponta M, Bill D, Moscato P, Lai C, Christie D, et al. Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial. Radiother Oncol 2009;90:400–7.
  • Gillespie C, Goode C, Hackett C, Andreyev HJN. The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2007; 26:555–63.
  • Faithfull S. ‘Just grin and bear it and hope that it will go away’: Coping with urinary symptoms from pelvic radiotherapy. Eur J Cancer Care Engl 1995;4:158–65.
  • Muls A, Watson L, Shaw C, Andreyev HJN. Managing gastrointestinal symptoms after cancer treatment. A practical approach for gastroenterologists. Frontline Gastroenterol 2013;4:57–68.
  • Andreyev HJN, Benton B, Lalji A, Norton C, Mohammed K, Gage H, et al. Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): A randomised controlled trial. Lancet 2013;382:2084–92.
  • Dukowicz A, Lacy B, Levine G. Small bowel bacterial overgrowth: A comprehensive review. Gastroenterol Hepatol 2007;3:112–22.
  • Quigley E, Quera R. Small intestinal bacterial overgrowth: Roles of antibiotics, prebiotics and probiotics. Gastroenterology 2006;130:S78–90.
  • Yeoh E, Horowitz M, Russo A, Muecke T, Robb T, Maddox A, et al. Effect of pelvic radiation on gastrointestinal function. Am J Med 1993;95:397–406.
  • Gasbarrini A, Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V, et al. Small intestinal bacterial overgrowth: Diagnosis and treatment. Dig Dis 2007;25:237–40.
  • Wedlake L, Thomas K, McCough C, Andreyev HJN. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study. Eur J Can 2008;44:2212–7.
  • Zaidel O, Lin H. Uninvited guests: The impact of small intestinal bacterial overgrowth on nutritional status. Prac Gastroenterol 2003;7:27–34.
  • Johnston I, Nolan J, Pattni SS, Walters JR. New insights into bile acid malabsorption. Curr Gastroenterol Rep 2011;13: 418–25.
  • Walters J, Pattni S. Managing bile acid malabsorption. Therap Adv Gastroenterol 2010;3:349–57.
  • Pattni S, Walters J. Recent advances in the understanding of bile acid malabsorption. Br Med Bull 2009;92:1–15.
  • Wedlake L, Hern R, Russell D, Thomas K, Walters J, Andreyev HJN. Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009;30: 707–17.
  • Harris V, Benton B, Sohaib A, Dearnaley D, Andreyev HJN. Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: An uncommon but treatable condition. Int J Radiat Oncol Biol Phys 2012;84:e601–6.
  • Kingham J, Barrett A. Pancreatic insufficiency following abdominal irradiation. Postgrad Med J 1980;56:804–5.
  • Dookeran K, Thompson M, Allum W. Pancreatic insufficiency secondary to abdominal radiotherapy. Eur J Surg Oncol 1993;19:95–6.
  • Chowdhury R, Forsmark C. Review article: Pancreatic function testing. Aliment Pharmacol Ther 2003;17:733–50.
  • Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: Present and future. Clin Exp Gastroenterol 2011;4:55–73.
  • Löser C, Möllgaard A, Fölsch U. Faecalelastase1: A novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996;39:580–6.
  • Andreyev HJN, Wotherspoon A, Denham J, Hauer-Jensen M. “Pelvic radiation disease”: New understanding and new solutions for a new disease in the era of cancer survivorship. Scand J Gastroenterol 2011;46:389–97.
  • Denton A, Andreyev HJN, Forbes A, Maher EJ. Systematic review for non-surgical interventions for the management of late radiation proctitis. Br J Can 2002;87:134–43.
  • Cullen S, Frenz M, Mee A. Treatment of haemorrhagic radiation-induced proctopathy using small volume topical formalin instillation. Aliment Pharmacol Ther 2006;23: 1575–9.
  • Sanguineti G, Franzone P, Marcenaro M, Foppiano F, Vitale V. Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study. Strahlenther Onkol 2003;179:464–70.
  • Konishi T, Watanabe T, Kitayama J, Shibahara J, Nagawa H. Endoscopic and histopathologic findings after formalin application for hemorrhage caused by chronic radiation- induced proctitis. Gastrointest Endosc 2005;61:161–4.
  • Raman R. Two percent formalin retention enemas for haemorrhagic radiation proctitis: A preliminary report. Dis Col Rectum 2007;50:1–8.
  • Shrom S, Donaldson M, Duckett J, Wein A. Formalin treatment for intractable hemorrhagic cystitis: A review of the literature with 16 additional cases. Cancer 1976;38:1785.
  • Rubinstein E, Ibsen T, Rasmussen R, Reimer E, Sorensen B. Formalin treatment of radiation-induced hemorrhagic proctitis. Am J Gastroenterol 1986;81:44–5.
  • Pitts C, Kearns A. Update on medications with adverse skeletal effects. Mayo Clin Proc 2011;86:338–43.
  • Muir J, Andrew M, Hirsh J, Weitz J, Young E, Deschamps P, et al. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood 1996;88: 1314–20.
  • Khoshknabi D. Muscle spasms. In: Walsh D, Caraceni AT, Fainsinger R, Foley K, Glare P, Goh C, et al., editors. Palliative Medicine, 1st ed. Philadelphia, Pa: Saunders Elsevier; 2008. Chapter 168.
  • Phillips K, Jim H, Small B, Laronga C, Andrykowski M, Jacobsen P. Cognitive functioning after cancer treatment. A 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer 2012;118:1925–32.
  • Mustian K, Morrow G, Carroll J, Figueroa-Moseley C, Jean-Pierre P, Williams G. Integrative nonpharmacologic behavioural interventions for the management of cancer related fatigue. Oncologist 2007;12(Suppl 1):52–67.
  • Kisiel-Sajewicz K, Davis M, Siemionow V, Seyidova-Khoshknabi D, Wyant A, Walsh D, et al. Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in patients with cancer-related fatigue. J Pain Symptom Manage 2012;44:351–61.
  • Ryan J, Carroll J, Ryan E, Mustian K, Fiscella K, Morrow G. Mechanisms of cancer-related fatigue. Oncologist 2007;12(Suppl 1):22–34.
  • Roscoe J, Kaufman M, Matteson-Rusby S, Palesh O, Ryan J, Kohli S, et al. Cancer-related fatigue and sleep disorders. Oncologist 2007;12(Suppl 1):35–42.
  • Bye A, Tropé C, Håvard Loge J, Hjermstad M, Kaasa S. Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy: Evaluation of long-term effects of diagnosis and treatment. Acta Oncol 2000;39:173–80.
  • Ahlberg K, Ekman T, Gaston-Johansson F. The experience of fatigue, other symptoms and global quality of life during radiotherapy for uterine cancer. Int J Nurs Stud 2005;42: 377–86.
  • Davies N, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: A review of the literature. Br J Cancer 2011;105(Suppl 1):S52–73.
  • Abrams P, Andersson K, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurol Urodyn 2010;29:213–40.
  • Wyndaele M, de Winter B, Pelckmans P, Wyndaele JJ. Lower bowel function in urinary incontinent women, urinary continent women and in controls. Neurol Urodyn 2011;30: 138–43.
  • Coyne K, Sexton C, Irwin D, Kopp Z, Kelleher C, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: Results from the EPIC study. Br J Urol Int 2008;101:1388–95.
  • Sundquist K. Sexuality and body image after cancer. Aust Fam Physician 2003;32:19–22.
  • Lange M, Marijnen C, Maas C, Putter H, Rutten H, Stiggelbout A, et al. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 2009;45:1578–88.
  • Sadovsky R, Basson R, Krychman M, Morales AM, Schover L, Wang R, et al. Cancer and sexual problems. J Sex Med 2010;7:349–73.
  • Vistad I, Cvancarova M, Fossa S, Kristensen G. Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: How well do physicians’ assessments agree with those of their patients?. Int J Radiat Oncol Biol Phys 2008;71:1335–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.